Physician profile
John P Gerace
NPI 1356428478
$8,594.33
in general payments reported to CMS, 2019-2025
54 companies · $1,004 in 2025
The $1,004 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,397 · 2020: $1,460 · 2021: $1,193 · 2022: $918 · 2023: $875 · 2024: $746 · 2025: $1,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,620 · Education: $5.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,619.66 |
| Education | $5.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,026.86 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $956.02 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Amgen INC. | $821.59 | 2019-2025 | Otezla, Repatha, Repatha |
| Amarin Pharma, INC. | $570.89 | 2019-2021 | |
| Novo Nordisk INC | $469.88 | 2019-2022 | |
| Pfizer INC. | $461.30 | 2019-2025 | |
| Glaxosmithkline, LLC. | $420.52 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Teva Pharmaceuticals USA, INC. | $346.00 | 2019-2023 | Airduo Digihaler, Ajovy |
| Lilly USA, LLC | $279.57 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $241.54 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $211.13 | 2019-2022 | |
| Axsome Therapeutics, INC. | $203.47 | 2023-2025 | Auvelity |
| Astellas Pharma US INC | $188.92 | 2020-2025 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $168.60 | 2019-2025 | Trintellix |
| Allergan, INC. | $140.56 | 2019-2020 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Gerace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.